Search

everythinglearnresearchcommunity

for

Search:↓

The research identified genes and non-coding RNAs in cells that could be affected by testosterone, which may help understand hair loss and prostate cancer.

Human hair follicles contain a complex network of prostanoid receptors that may influence hair growth.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Pregnancy-related hormone changes affect Y1 receptor gene expression in mice.

GLP-1 receptor agonists can help manage PCOS metabolism but need careful use before conception.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Dihydrotestosterone changes some hormone-related gene expressions in rat pituitary glands but doesn't affect the estrous cycle.

Blocking a protein called prostaglandin D2 might help treat hair loss.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Prolactin affects when mice shed and grow hair.

The enzyme PA-PLA1α is important for proper hair follicle development.

LPAR6 has a unique way of binding and activating, which helps in designing treatments for hair loss and cancer.

The retinoid receptor antagonist effectively disrupts vitamin A-related development in embryos.

A cream with a specific hormone blocker increases hair growth in mice.

Targeting the AhR pathway may help treat alopecia areata.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

SARMs work differently in tissues due to unique interactions and structures.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

Neuroactive steroids affect cocaine's rewarding effects through the ς₁ receptor.

Piperonylic acid may help hair growth and treat hair loss.

PRAME is often present in Paget disease and could help in diagnosis, but more research is needed.

Prolactin affects when mice shed and grow hair.